Sales & Marketing Why pharmacy-based engagement is pharma’s untapped adherence... Pharma companies can work alongside pharmacists to deliver personalised outreach that informs patient treatment decisions and drives adherence.
Digital Digital transformation as a third lever in the affordability... Alfred Olivares, global managing partner, healthcare & medtech, at HTEC, discusses how AI and tech can help address the affordability challenge.
R&D Opportunity costs of gene therapies. Where do we go from her... Over 30 gene therapies have received regulatory approval.
News AscellaHealth recognised for rare disease funding programme AscellaHealth has been given an industry award for a financial solution designed to meet the affordability challenges of expensive treatments for rare and complex diseases
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.